OSE Immunotherapeutics (LTS:0RAD) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RAD OSE Immunotherapeutics SA LTS:0RAD
51 GF Score
Price €3.27
GF Value €1.51
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is OSE Immunotherapeutics FFO per Share?

FFO per Share only applies to REITs.

LTS:0RAD
51GF Score
OSE Immunotherapeutics SA LTS:0RAD
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OSE Immunotherapeutics (LTS:0RAD) Overvalued in 2026?

Based on GuruFocus' analysis, OSE Immunotherapeutics stock appears to be overvalued. The current stock price of €3.27 is trading 116.6% above its estimated GF Value™ of €1.51. GuruFocus considers OSE Immunotherapeutics to be Significantly Overvalued.

Key valuation signals for LTS:0RAD:

  • FFO per Share:
  • GF Value™: €1.51 vs. price of €3.27 (116.6% above fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OSE Immunotherapeutics Business Description

Address 22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
51GF Score

Get the complete analysis for LTS:0RAD

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.27
Price
€1.51
GF Value